These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25711068)

  • 21. Clinical correlations of dry eye syndrome and allergic conjunctivitis in Korean children.
    Kim TH; Moon NJ
    J Pediatr Ophthalmol Strabismus; 2013; 50(2):124-7. PubMed ID: 23316947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of duration of contact lens wear on the structure and function of the meibomian glands.
    Alghamdi WM; Markoulli M; Holden BA; Papas EB
    Ophthalmic Physiol Opt; 2016 Mar; 36(2):120-31. PubMed ID: 26890701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Microblepharon Exfoliation on Clinical Correlates of Contact Lens Discomfort.
    Siddireddy JS; Tan J; Vijay AK; Willcox MDP
    Optom Vis Sci; 2019 Mar; 96(3):187-199. PubMed ID: 30801507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic relief associated with eyelid hygiene in anterior blepharitis and MGD.
    Guillon M; Maissa C; Wong S
    Eye Contact Lens; 2012 Sep; 38(5):306-12. PubMed ID: 22890228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of different lubricant eye gels on tear film thickness as measured with ultrahigh-resolution optical coherence tomography.
    Wozniak PA; Schmidl D; Bata AM; Fondi K; Witkowska KJ; Aranha Dos Santos V; Baar C; Room KI; Nepp J; Baumgartner I; Popa-Cherecheanu A; Garhöfer G; Werkmeister RM; Schmetterer L
    Acta Ophthalmol; 2017 Jun; 95(4):e307-e313. PubMed ID: 27989018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease.
    Pinto-Fraga J; López-de la Rosa A; Blázquez Arauzo F; Urbano Rodríguez R; González-García MJ
    Eye Contact Lens; 2017 Jan; 43(1):57-63. PubMed ID: 26783978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study.
    Doan S; Chiambaretta F; Baudouin C;
    J Fr Ophtalmol; 2014 Dec; 37(10):763-72. PubMed ID: 25282620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosing and managing allergic conjunctivitis in childhood: The allergist's perspective.
    Fauquert JL
    Pediatr Allergy Immunol; 2019 Jun; 30(4):405-414. PubMed ID: 30742722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ophthalmoferon efficacy in the treatment of children with chronic blepharoconjunctivitis].
    Prozornaya LP; Brzheskiy VV
    Vestn Oftalmol; 2017; 133(5):49-55. PubMed ID: 29165413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Lipid- Versus Sodium Hyaluronate-Containing Eye Drops on Optical Quality and Ocular Surface Parameters as a Function of the Meibomian Gland Dropout Rate.
    Miháltz K; Faschinger EM; Vécsei-Marlovits PV
    Cornea; 2018 Jul; 37(7):886-892. PubMed ID: 29377842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction.
    Pinna A; Piccinini P; Carta F
    Cornea; 2007 Apr; 26(3):260-4. PubMed ID: 17413949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Artificial tear drops Thealoz in the correction of dry eye syndrome after keratorefractive surgery].
    Panova IE; Titov AV; Golovatenko SP; Mirsaitova DR; Leshchik OP; Pogosyan MA
    Vestn Oftalmol; 2019; 135(2):113-121. PubMed ID: 31215542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study.
    Kiss HJ; Németh J
    PLoS One; 2015; 10(7):e0132656. PubMed ID: 26172053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment.
    Souchier M; Joffre C; Grégoire S; Bretillon L; Muselier A; Acar N; Beynat J; Bron A; D'Athis P; Creuzot-Garcher C
    Br J Ophthalmol; 2008 Jun; 92(6):819-22. PubMed ID: 18511542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial.
    Lee H; Chung B; Kim KS; Seo KY; Choi BJ; Kim TI
    Am J Ophthalmol; 2014 Dec; 158(6):1172-1183.e1. PubMed ID: 25128594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of an Artificial Tear Containing 0.3% Hyaluronic Acid in the Management of Moderate-to-Severe Dry Eye Disease.
    López-de la Rosa A; Pinto-Fraga J; Blázquez Arauzo F; Urbano Rodríguez R; González-García MJ
    Eye Contact Lens; 2017 Nov; 43(6):383-388. PubMed ID: 27243353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Meibomian gland dysfunction--review].
    Nowińska A; Wylegała E; Tarnawska D; Janiszewska D; Dobrowolskia D
    Klin Oczna; 2012; 114(2):147-52. PubMed ID: 23346806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blepharitis: current strategies for diagnosis and management.
    Jackson WB
    Can J Ophthalmol; 2008 Apr; 43(2):170-9. PubMed ID: 18347619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contact Lens-Associated Dry Eye Disease: Recent Advances Worldwide and in Japan.
    Kojima T
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES102-DES108. PubMed ID: 30481813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.